Cutaneous leukemia is characterized by red or purple slightly elevated papules or nodules; patients with cutaneous myelofibrosis may also develop red or purple slightly elevated papules or nodules. Cutaneous leukemia is a malignancy of the white blood cells in the blood and is characterized by diffuse infiltration of the bone marrow by immature leukocytes and abnormal numbers of immature leukocytes in the blood. In addition, immature leukocytes often infiltrate extensively the liver, spleen, lymph nodes and other organs, including the skin. Cutaneous myelofibrosis, also known as cutaneous extramedullary hematopoiesis, is a chronic myeloproliferative disease. So how can red or purple, slightly elevated papules or nodules be prevented? Here’s what you need to know. Prevention: Cutaneous myelofibrosis : (a) Treatment The main treatment is myelofibrosis or true erythropoietic hyperplasia. Alleviate the clinical symptoms of extramedullary hematopoiesis. (B) Prognosis Slightly elevated purplish red or dark blue papules that appear during the postnatal period in newborns with purple and black berry muffin syndrome usually resolve within 4 to 6 weeks. Cutaneous leukemia: (i) Treatment Atopic lesions can be treated with radiation and local chemotherapy or chemotherapy. (B) Prognosis Patients with acute leukemia often die rapidly if left untreated Current treatments can only prolong their survival Chronic granulocytic leukemia and chronic lymphocytic leukemia survive an average of about 40 months after diagnosis Chronic lymphocytic leukemia is less common than chronic granulocytic leukemia and can survive for more than 10 years.